黑料官网

header-logo
GettyImages-609179959-hero
headshot

Anita D'Souza, MD

Associate Chief, Research, Division of Hematology/Oncology; Professor of Medicine

view physician profile

Locations

  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Hematology
  • Medical Oncology

Languages

  • English, Hindi

Clinical Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

Anita D’Souza, MD, MS completed medical school in Goa Medical College, India where she graduated at the top of her class and was voted Best Medical Graduate. She completed her Hematology and Medical Oncology fellowship at the Mayo Clinic, Minnesota.

Research Interests

Dr. D'Souza's clinical and research work is focused on plasma cell cancers (e.g. multiple myeloma, AL amyloidosis, POEMS syndrome, Waldenstrom Macroglobulinemia) and the use of hematopoietic cell transplantation to treat these diseases. She serves as a scientific director of the Plasma Cell Disorders and Adult Solid Tumors working committee in the Center for International Blood and Marrow Transplant Research (CIBMTR). She is principal investigator on clinical trials in amyloidosis and multiple myeloma. She is a recipient of the 2016 KL2 Career Development Award from the Clinical and Translational Science Institute. Dr. D’Souza is board certified in Internal Medicine, Hematology and Medical Oncology.

Publications

  • (Shrestha A, Thanendrarajan S, Bag A, Dhakal B, Zangari M, Al-Hadidi S, van Rhee F, D'Souza A, Shah N, Shah MR, Mohan M, Schinke C.) Blood Adv. 2025 Oct 14;9(19):4806-4809 PMID: 40674710 PMCID: PMC12494909 SCOPUS ID: 2-s2.0-105017267704 07/17/2025

  • (Henley EC, Liphart HA, Morris KJ, Awoyinka I, Irwin MR, Costanzo ES, Winston D, D'Souza A, Stolley M, Dhakal B, Mohan M, Pasquini MC, Cole SW, Doerwald ES, Bendis PC, Rentscher KE, Rumble ME, Szabo A, Rao S, Knight JM.) Contemp Clin Trials Commun. 2025 Oct;47:101540 PMID: 40893725 PMCID: PMC12397865 09/02/2025

  • (Yadav K, Mohan M, Wagner C, Chakraborty R, Sborov D, Godara A, McClune B, Schinke C, Dhakal B, D'Souza A, Szabo A, Mohyuddin GR.) Leukemia. 2025 Sep;39(9):2289-2291 PMID: 40670671 SCOPUS ID: 2-s2.0-105011037613 07/17/2025

  • (Vandenboom H, Akhtar O, Szabo A, Narra R, Mohan M, D'Souza A, Pasquini M, Dhakal B.) Haematologica. 2025 Aug 14 PMID: 40820831 08/18/2025

  • (Mizuno S, Gras L, Baaij LGA, Koster L, D'Souza A, Hari PN, Estrada-Merly N, Saber W, Cowan AJ, Iida M, Okamoto S, Takamatsu H, Kawamura K, Kodera Y, Hamad N, Ko BS, Liam C, Ho KW, Goh AS, Keat TS, Elhaddad AM, Bazarbachi A, Chaudhry BQUN, Alfar R, Bekadja MA, Benakli M, Ortiz CAF, Riva E, Verburgh E, Galeano S, Bass F, Mian H, McCurdy A, Wang FR, Neumann D, Koh MBC, Snowden JA, Schönland S, McLornan DP, Hayden PJ, Balari AMS, Greinix HT, Aljurf M, Atsuta Y, Rondelli D, Niederwieser DW, Garderet L.) Haematologica. 2025 Jul 31 PMID: 40820767 08/18/2025

  • (Wu JF, Akinola IM, D'Souza A, Cusatis R.) Clin Lymphoma Myeloma Leuk. 2025 Jul 11 PMID: 40744761 PMCID: PMC12357161 08/01/2025

  • (Naiki H, Johnson M, Walters K, Carpinteiro A, Cibeira MT, D'Souza A, Kastritis E, Maurer MS, Mendelson L, Merlini G, Muchtar E, Palladini G, Riva E, Sekijima Y, Westermark P, Kumar S, Schönland SO.) Amyloid. 2025 Jun;32(2):139-144 PMID: 39928315 02/10/2025

  • (Dittrich T, Weinert L, D'Souza A.) Blood Rev. 2025 May 20:101303 PMID: 40413080 PMCID: PMC12354096 05/25/2025

  • (Estrada-Merly N, Wu JF, Pezzin LE, Nataliansyah MM, D'Souza A.) Eur J Haematol. 2025 May;114(5):890-899 PMID: 39957265 02/17/2025

  • (Mohan M, Szabo A, Cheruvalath H, Clennon A, Bhatlapenumarthi V, Patwari A, Balev M, Bhutani D, Shrestha A, Thanendrarajan S, Dhakal B, Zangari M, Trikannad A, Vellanki S, Al-Hadidi S, Lentzsch S, van Rhee F, Bag A, D'Souza A, Shah N, Chakraborty R, Shah MR, Schinke C.) Blood Cancer J. 2025 Apr 23;15(1):74 PMID: 40268898 PMCID: PMC12018942 SCOPUS ID: 2-s2.0-105003139880 04/24/2025

  • (Chunara F, Lugo C, Osinski K, Shah MR, Shah N, Kent J, Mohyuddin GR, Radhakrishnan SV, Kaur G, Chakraborty R, Banerjee R, Rasche L, Schinke C, D'Souza A, Szabo A, Mohan M.) Blood Cancer J. 2025 Apr 08;15(1):61 PMID: 40199861 PMCID: PMC11979001 SCOPUS ID: 2-s2.0-105003231303 04/09/2025

  • (Li SS, D'Souza A, Lentzsch S, Zafar F, Pivneva I, Watson T, Guerin A, Kumar S.) Clin Lymphoma Myeloma Leuk. 2025 Mar 28 PMID: 40287350 04/27/2025

Publications of Anita D'Souza MD from the

© 2025 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.